BrainsWay Ltd. is a global medical technology company focused on the development and commercialization of its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking addiction. Their non-invasive treatments offer an alternative for patients who have not responded to other therapies. BrainsWay is committed to advancing neuroscience and improving patient outcomes through innovative medical devices.
The Jerusalem headquarters serves as the central hub for research and development, global operations, manufacturing, strategic planning, and corporate administration.
Located in Har Hotzvim, a major high-tech park in Jerusalem, facilitating collaboration and access to talent. Likely houses advanced R&D labs for neurostimulation technology.
A dynamic and innovative environment, driven by a mission to improve mental health. Emphasis on scientific rigor, collaboration between engineering, clinical, and commercial teams, and a patient-centric approach.
The headquarters is critical for BrainsWay's core innovation in Deep TMS technology, global strategy execution, and oversight of its worldwide commercial activities.
BrainsWay supports global functions including research and development primarily from its headquarters in Israel. Commercial operations, including sales, marketing, clinical support, and distribution, are managed through its U.S. subsidiary for North America and through a network of distributors and direct presence in other international markets across Europe and Asia-Pacific.
19 Hartum St., Bynet Building, 3rd Floor, Har Hotzvim
Jerusalem
Jerusalem District
Israel
Address: 3 University Plaza Dr, Suite 105, Hackensack, NJ 07601, USA
To drive market adoption, support healthcare providers, and expand patient access to Deep TMS therapy within the United States, a key market for medical technology.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BrainsWay' leadership includes:
BrainsWay has been backed by several prominent investors over the years, including:
BrainsWay has seen some key executive appointments in the recent period, notably strengthening its financial leadership. Scott Areglado was appointed CFO in early 2023.
Discover the tools BrainsWay uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BrainsWay most commonly uses the email format combining the first initial and last name, or first name.lastname. Common variations are checked to provide a comprehensive list.
[first_initial][last]@brainsway.com or [first].[last]@brainsway.com
Format
jdoe@brainsway.com or jane.doe@brainsway.com
Example
80%
Success rate
GlobeNewswire • May 15, 2024
BrainsWay announced its financial results for the first quarter ended March 31, 2024, reporting revenues of $7.7 million and highlighting progress in system installations and utilization....more
GlobeNewswire • March 6, 2024
BrainsWay reported record revenue of $32.8 million for the full year 2023, an 18% increase over 2022. The company also highlighted its operational achievements and strategic priorities for continued growth....more
GlobeNewswire • February 20, 2024
BrainsWay announced FDA clearance for its Deep TMS system with the H7-coil for reducing comorbid anxiety symptoms in adult patients with depression, also known as anxious depression. This clearance expands the application of their technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BrainsWay, are just a search away.